QCG
KURA icon

Quadrant Capital Group’s Kura Oncology KURA Stock Holding History

Quadrant Capital Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,900
Closed -$23.6K – 1949
2026
Q1 		$23.6K Buy
2,900
+1,066
+58% +$9.16K ﹤0.01% 1948
2025
Q4 		$19.1K Hold
1,834
– – ﹤0.01% 2014
2025
Q3 		$16.2K Buy
+1,834
New +$13.1K ﹤0.01% 2017
2025
Q2 		– Sell
-2,344
Closed -$15.5K – 2019
2025
Q1 		$15.5K Buy
2,344
+714
+44% +$5.56K ﹤0.01% 2111
2024
Q4 		$14.2K Sell
1,630
-60
-4% -$863 ﹤0.01% 2017
2024
Q3 		$33K Sell
1,690
-7
-0.4% -$142 ﹤0.01% 1672
2024
Q2 		$34.9K Sell
1,697
-62
-4% -$1.27K ﹤0.01% 1588
2024
Q1 		$37.5K Buy
1,759
+69
+4% +$1.34K ﹤0.01% 1548
2023
Q4 		$24.3K Buy
1,690
+1,642
+3,421% +$16.1K ﹤0.01% 1724
2023
Q3 		$438 Buy
48
+30
+167% +$305 ﹤0.01% 2587
2023
Q2 		$191 Sell
18
-1,369
-99% -$16.2K ﹤0.01% 2658
2023
Q1 		$17K Buy
+1,387
New +$17.3K ﹤0.01% 1781
2022
Q3 		– Sell
-52
Closed -$1K – 2724
2022
Q2 		$1K Sell
52
-9
-15% -$129 ﹤0.01% 2390
2022
Q1 		$1K Buy
+61
New +$881 ﹤0.01% 2330
2020
Q2 		– Sell
-16
Closed – – 2315
2020
Q1 		$0 Buy
+16
New +$183 ﹤0.01% 2186

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Quadrant Capital Group's KURA Position: Q2 2026 in Review

Quadrant Capital Group sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 2,900 shares — an estimated $23.6K sold.

Quadrant Capital Group first reported a position in KURA in Q1 2020 and held it in 15 quarters. The position peaked at $37.5K in Q1 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Quadrant Capital Group reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 2,900 Kura Oncology shares in Q2 2026, an estimated $23.6K.
  • Quadrant Capital Group first reported a position in Kura Oncology in Q1 2020 and held it in 15 quarters.
  • Quadrant Capital Group's Kura Oncology position peaked at $37.5K in Q1 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.